Willem E Fibbe

International Society for Cellular Therapy perspective on immune functional assays for mesenchymal stromal cells as potency release criterion for advanced phase clinical trials.

Ivan Martin, John Barrett, Donald G Phinney, 2016, Cytotherapy.

Mesenchymal stem cells promote engraftment of human umbilical cord blood-derived CD34(+) cells in NOD/SCID mice.

J. Falkenburg, M. Heemskerk, R. Willemze, 2002, Experimental hematology.

Allogeneic Bone Marrow-Derived Mesenchymal Stromal Cells Promote Healing of Refractory Perianal Fistulas in Patients With Crohn's Disease.

Roeland A Veenendaal, Bert A Bonsing, Hein W Verspaget, 2015, Gastroenterology.

Human adult bone marrow mesenchymal stem cells repair experimental conduction block in rat cardiomyocyte cultures.

Martin J Schalij, Arnoud van der Laarse, Douwe E Atsma, 2005, Journal of the American College of Cardiology.

Cotransplantation of ex vivo expanded mesenchymal stem cells accelerates lymphocyte recovery and may reduce the risk of graft failure in haploidentical hematopoietic stem-cell transplantation.

Franco Locatelli, A. Cometa, F. Locatelli, 2007, Blood.

Mesenchymal stem cells in human second-trimester bone marrow, liver, lung, and spleen exhibit a similar immunophenotype but a heterogeneous multilineage differentiation potential.

R. Willemze, A. Kruisselbrink, W. Fibbe, 2003, Haematologica.

Rituximab improves the treatment results of DHAP-VIM-DHAP and ASCT in relapsed/progressive aggressive CD20+ NHL: a prospective randomized HOVON trial.

E. Vellenga, W. van Putten, J. Zijlstra, 2006, Blood.

Canonical wnt signaling regulates hematopoiesis in a dosage-dependent fashion.

Frank J T Staal, Riccardo Fodde, J. V. van Dongen, 2011, Cell stem cell.

Defining the risks of mesenchymal stromal cell therapy.

Donald G Phinney, Armand Keating, Luc Sensebe, 2010, Cytotherapy.